Mordor Intelligence has published a new report on the Pharmaceutical Intermediates Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The global pharmaceutical intermediates market is projected to grow from USD 45.45 billion in 2025 to USD 65.01 billion by 2030, registering a compound annual growth rate (CAGR) of 7.42% during the forecast period. This growth is primarily attributed to increasing healthcare expenditure and infrastructure development worldwide.
Pharmaceutical intermediates are chemical compounds that serve as building blocks in the production of active pharmaceutical ingredients (APIs). They play a crucial role in the synthesis of various drugs, including analgesics, anti-infective agents, and cardiovascular medications. The rising demand for effective and safe medications, coupled with advancements in drug development processes, is fueling the growth of the pharmaceutical intermediates market.
Pharmaceutical Intermediates Market Key Trends
-
Rising Healthcare Expenditure
Global healthcare spending has seen a significant increase, providing a robust foundation for the pharmaceutical intermediates market. For instance, in the United States, healthcare expenditure rose by 9.7% to reach USD 4.3 trillion in 2021, compared to a 4.2% increase in 2020. This surge in spending underscores the growing emphasis on healthcare infrastructure and services, thereby boosting the demand for pharmaceutical intermediates.
-
Infrastructure Development in Emerging Economies
Emerging economies are witnessing substantial investments in healthcare infrastructure, leading to increased demand for pharmaceutical intermediates. The expansion of hospitals, clinics, and research institutions in these regions necessitates a steady supply of medications, thereby driving the market for intermediates used in drug synthesis.
-
Technological Advancements in Drug Development
The pharmaceutical industry is increasingly adopting advanced technologies to enhance drug development processes. Techniques such as high-throughput screening, bioinformatics, and combinatorial chemistry are being utilized to identify potential drug candidates more efficiently. Additionally, the integration of artificial intelligence in drug discovery is enabling faster and more cost-effective development of pharmaceutical intermediates.
-
Strategic Investments and Acquisitions
Companies are making strategic investments to expand their manufacturing capabilities and strengthen their market position. For example, in March 2022, Sumitomo Chemical Co., Ltd announced plans to construct a new manufacturing plant for active pharmaceutical intermediates and intermediates in Japan, scheduled to commence operations in September 2024.
Pharmaceutical Intermediates Market Segmentation
The pharmaceutical intermediates market is segmented based on type, application, end-user, and geography:
-
By Type:
- Chemical Intermediates
- Bulk Drug Intermediates
- Others
-
By Application:
- Analgesics
- Anti-Infective Drugs
- Cardiovascular Drugs
- Oral Antidiabetic Drugs
- Antimicrobial Drugs
- Others
-
By End-User:
- Biotech and Pharma Companies
- Research Institutions
- Others
-
By Geography:
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
This segmentation allows for targeted strategies to address specific needs within each category, ensuring comprehensive coverage options for various patient populations.
Explore Our Full Library of Pharmaceuticals Research Industry Reports – https://www.mordorintelligence.com/market-analysis/pharmaceuticals
Key Players
Several companies are leading the pharmaceutical intermediates market, contributing to its growth through research, product development, and strategic collaborations:
- Chiracon GmbH: Specializes in the production of pharmaceutical intermediates and active pharmaceutical ingredients.
- BASF SE: Offers a range of chemical products, including intermediates used in pharmaceutical manufacturing.
- Sanofi SAIS: Engages in the development and production of pharmaceutical products, including intermediates.
- Aceto: Provides specialty chemicals and pharmaceutical intermediates to various industries.
- Codexis, Inc.: Focuses on enzyme engineering and biocatalysis for pharmaceutical intermediate production.
These organizations are recognized for their extensive research initiatives and commitment to advancing pharmaceutical intermediate solutions.
Conclusion
The pharmaceutical intermediates market is on a growth trajectory, driven by increasing healthcare expenditure, infrastructure development, technological advancements, and strategic investments. With a projected market size of USD 65.01 billion by 2030, the sector presents significant opportunities for companies involved in the production and development of pharmaceutical intermediates. As the global demand for effective and safe medications continues to rise, the importance of pharmaceutical intermediates in the drug development process becomes increasingly evident.
Industry Related Reports
China Active Pharmaceutical Ingredients (API) Market: The Chinese Active Pharmaceutical Ingredients (API) Market Report is Segmented by Business Mode (Captive API and Merchant API), Synthesis Type (Synthetic and Biotech), Drug Type (Generic and Branded), and Application (Cardiology, Oncology, Pulmonology, Neurology, Orthopedic, Ophthalmology, and Other Applications).
Indian Pharmaceutical Market: The India Pharmaceutical Market is segmented by Therapeutic Category (Anti-Infectives, Cardiovascular, Gastrointestinal, Anti Diabetic, Respiratory, Dermatologicals, Musculo-Skeletal System, Nervous System, and Others) and Drug Type (Prescription Drugs (Branded Drugs and Generic Drugs), and Over Counter Drugs).
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/